Business Economics and Public Policy, Healthcare
A new study led by Neal Masia, Vice President of Patient & Health Impact at Pfizer, and Adjunct Professor of Business in the Management Division at Columbia Business School in New York, assessed how changes in childhood vaccine investment impact a country's gross domestic product (GDP). Using the DTP (diphtheria, tetanus and pertussis) as a proxy for vaccination programs generally, the research findings show that improved childhood vaccination rates were associated with economic growth, suggesting a significant and long-term increases in the GDP growth rate.